References
- van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643–7
- De Plaen E, Arden K, Traversari C, et al. Structure, chromosome localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360–9
- Wang M G, Zakut R, Yi H, Rosenberg S, McBride OW. Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28. Cytogenet Cell Genet 1994; 67: 116–9
- Oaks M K, Hanson JP, Jr, O'Malley DP. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Cancer Res 1994; 54: 1627–9
- Marchand M, Brasseur F, van der Bruggen P, et al. Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1. Dermatology 1993; 186: 278–80
- Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors [letter]. Int J Cancer 1992; 52: 839–41
- Zakut R, Topalian S L, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA. Differential expression of MAGE-1, -2 and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 1993; 53: 5–8
- Rimoldi D, Romero P, Carrel S. The human melanoma antigen-encoding gene, MAGE-1 is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas [letter]. Int J Cancer 1993; 54: 527–8
- De Smet C, Lurquin C, van der Bruggen P, De Plaen E, Brasseur F, Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994; 39: 121–9
- Weynants P, Lethe B, Brasseur F, Marchand M, Boon T. Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 1994; 56: 826–9
- Eura M, Chikamatsu K, Ogi K, Nakano K, Masuyama K, Ishikawa T. Expression of genes MAGE-1, -2 and -3 by human maxillary carcinoma cells. Anticancer Res 1995; 15: 55–60
- Gaugler B, van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigenrecognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179: 921–30
- Stevens E J, Jacknin L, Robbins P F, et al. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J Immunol 1995; 1544: 762–71
- Shimizu Y, Iwatsuki S, Herberman R B, Whiteside TL. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer 1990; 46: 878–83
- Aruga A, Yamauchi K, Takasaki K, Furukawa T, Hanyu F. Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterization and clinical utilization. Int J Cancer 1991; 49: 19–24
- Brichard V A, van Pel T, Wolfel C, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489–95
- Bakker A BH, Schreurs M WJ, De Boer A J, et al. Melanocyte lineage-specific antigen gplOO is recognized by melanocyte-derived tumor infiltrating lymphocytes. J Exp Med 1994; 179: 1005–9
- Coulie P G, Brichard V, van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-2 melanomas. J Exp Med 1994; 180: 35–42
- Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994; 180: 347–52
- Wang R F, Robbins P F, Kawakami Y, Kang X Q, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by H LA-A31 -restricted tumor-infiltrating lymphocytes. J Exp Med 1995; 181: 799–804
- Becker J C, Gillitzer R, Brocker EB. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1994; 58: 346–8